Assistant Professor, Department of Neurology, Neuroimmunology and Multiple Sclerosis; Director, Neuroimmunology and MS Fellowship Program, The Medical College of Wisconsin

Adjunct professor of neurology, University of North Carolina School of Medicine

Assistant professor of neurology; director, MS and Neuroimmunology Fellowship Program, Duke Health

Diagnosing Multiple Sclerosis in 1990 vs 2020

Barriers to Treating Multiple Sclerosis

Monitoring for Drug Safety in Multiple Sclerosis 

Role of Multiple Sclerosis Therapeutics 

Future Treatment Landscape for Multiple Sclerosis 

Multiple Sclerosis: Advice for Patients and Trainees

Importance of Early Treatment for Multiple Sclerosis

Closing Remarks on Treatment of Multiple Sclerosis 

Audience Questions: Approaching DMT in Multiple Sclerosis 


Assistant Professor, Department of Neurology, Neuroimmunology and Multiple Sclerosis; Director, Neuroimmunology and MS Fellowship Program, The Medical College of Wisconsin

Director, MS & Neuroimmunology Fellowship, Duke University School of Medicine


Adjunct Professor of Neurology, University of North Carolina-Chapel Hill

Virtual patient visits during COVID-19 when treating MS

Evolution of monitoring safety and efficacy of therapy

Leaders In Neurology

SAP Partners

Multiple Sclerosis

EMD-22-NRD0193 - /clinical/multiple-sclerosis

 multiple sclerosis (MS) clinical focus page offers information, podcasts, videos, and news about the latest study and clinical trial findings, FDA actions, clinical guideline updates, and expert interviews related to the care and management of patients with MS, including relapsing MS and progressive MS, as well as related disorders such as neuromyelitis optica spectrum disorder.

Videos

News

The Ever-Changing Face of Multiple Sclerosis

's Future Leaders in Neurology seeks to connect the next generation of up-and-coming neurologists, advanced practice providers, and other healthcare professionals with individuals who have cultivated a range of clinical experiences. Together, they will share insights and perspectives to help mold the key thought leaders of tomorrow.

Leaders in Neurology

The Consortium of Multiple Sclerosis Centers

SAP Partner

Experts in multiple sclerosis (MS) provide insight on approaching the diagnosis of MS in 1990 vs 2020 and the role of disease-modifying therapies (DMT) in disease management.

Join Ahmed Obeidat, MD, PhD; Mitchell Freedman, MD; and Suma Shah, MD, for the second program of this monthly series as they discuss the evolution of therapeutics for the treatment of multiple sclerosis.

Latest News